Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle

Gustave Roussy

Status and phase: Unknown; Phase 2

Conditions: Sarcoma of Pelvis

Treatments: Drug: Tasonermine (TNFa); Drug: Melphalan

Study type: Interventional

Funder types: Other

Identifiers

NCT00181025

CSET 2003/1053

PIP

Details and patient eligibility

About

This study looks at isolated pelvic perfusion and limbs' girdle with 1 mg tumor necrosis factor alpha (TNFa) in the treatment of locally advanced sarcoma of the pelvis and limbs' girdle.

Enrollment: 33 estimated patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Soft tissue or bone sarcomas locally advanced of the pelvis or limbs' girdle

Exclusion criteria

• Resectable tumor without mutilation

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)